What is THREAD?
THREAD operates a decentralized research platform designed to broaden access to studies globally. The company provides biopharma and contract research organizations (CROs) with integrated clinical research technology and consulting services. These offerings facilitate the design, operation, and scaling of next-generation research studies and electronic clinical outcome assessments (eCOA) programs. THREAD's platform and scientific acumen aim to make studies more accessible, efficient, and patient-centric. The company has been recognized as a leader in decentralized clinical trials by industry assessments from Everest Group and IDC MarketScape.
How much funding has THREAD raised?
THREAD has raised a total of $50M across 1 funding round:
Private Equity
$50M
Private Equity (2020): $50M with participation from JLL Partners and Water Street
Key Investors in THREAD
JLL Partners
JLL Partners is a private equity firm that invests in a range of industries, often focusing on growth-oriented companies. Their involvement suggests a strategic interest in THREAD's expansion and market development.
Water Street
Water Street Health Care Partners is a private equity firm exclusively focused on the health care sector. Their investment in THREAD highlights a strong belief in the company's potential within the healthcare and clinical research landscape.
What's next for THREAD?
The recent major strategic investment signals a phase of accelerated growth and market expansion for THREAD. With its established leadership in decentralized clinical trial technology, the company is well-positioned to further scale its operations and enhance its platform capabilities. This capital infusion will likely support advancements in its technology, broaden its service offerings, and strengthen its market presence, enabling more comprehensive and patient-focused research studies worldwide.
See full THREAD company page
